Cuga S 50 mg/15 mg Capsule belongs to the class of drugs known as 'non-steroidal anti-inflammatory drug' (NSAID). It is a fixed-dose combination composed of diclofenac and serratiopeptidase. Pain can be temporary (acute) or lifelong (chronic) in nature. Acute pain is for short time caused by damage to the tissues of the muscle, bone, or organs. While, chronic pain lasts for life long caused due to nerve damage, osteoarthritis, and dental pain due to damage of the tooth nerve, infection, decay, extraction, or injury.

Cuga S 50 mg/15 mg Capsule is used in the reduction of pain and inflammation due to bone or soft tissue injury, resolution of postoperative inflammation, oedema (swollen tissue with fluid) and pain. Diclofenac works by blocking the action of a chemical messenger known as cyclo-oxygenase (COX) which causes pain and swelling at the injured or damaged tissue. Serratiopeptidase is a proteolytic enzyme which helps in the breakdown of insoluble protein (fibrin) a by-product of blood clots into smaller units. It also causes thinning of the fluids in the body as a result of injury, thereby making fluid drainage smoother in the swollen tissue.

You can take Cuga S 50 mg/15 mg Capsule with food or without food. It should be swallowed whole with a glass of water. Do not chew, bite, or break it. Your doctor will advise you on how often you take Cuga S 50 mg/15 mg Capsule based on your medical condition. Cuga S 50 mg/15 mg Capsule may have common side effects like stomach ache, diarrhoea, nausea (feeling sick), and indigestion. Most of these side effects of Cuga S 50 mg/15 mg Capsule do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Try not to stop taking this medicine of your own. Do not take Cuga S 50 mg/15 mg Capsule if you are allergic to painkillers like aspirin, ibuprofen, naproxen, or diclofenac. It is not recommended for use in children. Cuga S 50 mg/15 mg Capsule may be associated with a small increased risk of heart attack ‘myocardial infarction. It is advisable not to exceed the recommended dose or duration of treatment.

Cuga S 50 mg/15 mg Capsule plays a vital role in reducing pain and inflammation by blocking the release of chemical messengers which cause pain and fever. Cuga S 50 mg/15 mg Capsule relieves pain and inflammation in arthritic conditions with the benefit of increased antibiotic penetration and micro-circulation at the injury site. Serratiopeptidase present in Cuga S 50 mg/15 mg Capsule is a proteolytic enzyme which helps in the breakdown of insoluble protein (fibrin) a by-product of blood clots into smaller units. It also causes thinning of the fluids in the body as a result of injury, thereby making fluid drainage smoother in the swollen tissue.

Consumption of alcohol should be avoided during the treatment with Cuga S 50 mg/15 mg Capsule as it may lead to an increase in the risk of liver damage. Patients with a stomach ulcer, gastric bleeding, severe heart failure, stroke, and hypertension (high blood pressure), should not take Cuga S 50 mg/15 mg Capsule. Besides this, it should be avoided during the last trimester of pregnancy, unless there are compelling reasons for doing so. If you have a severe allergy to pain killers and, complications like asthma, rhinitis, angioedema (swelling under the skin) or skin rashes, immediately stop taking Cuga S 50 mg/15 mg Capsule. Do not drive or operate heavy machinery as intake of Cuga S 50 mg/15 mg Capsule may cause dizziness. Patients who had recently undergone heart bypass surgery should take Cuga S 50 mg/15 mg Capsule with caution and only under medical supervision. Use of Cuga S 50 mg/15 mg Capsule is contraindicated in kidney failure patients or who are undergoing dialysis.